
Sigma Healthcare (ASX: SIG) delivers strong double‑digit growth and disciplined integration, positioning the merged Chemist Warehouse group for sustained expansion across domestic and international markets
.webp&w=828&q=75)
Island Pharmaceuticals has regained market attention after breaking a long-term downtrend, supported by Galidesivir developments and strong trading momentum. Recent updates across biodefence, manufacturing, and intellectual property have improved sentiment, although confirmation above key resistance remains important

DevEx Resources (ASX: DEV) is an Australian uranium explorer advancing its flagship Nabarlek project. While buoyed by strong uranium markets and strategic acquisitions, the consolidating stock faces high exploration risks, significant cash burn, and reliance on upcoming drilling success

Core Lithium (ASX: CXO) advances its Finniss restart with full funding, disciplined execution, and improving lithium sentiment, positioning for a tactical rebound as operations resume and technical momentum builds.
.webp&w=828&q=75)
Cobre is shifting from exploration to production, backed by positive cash flow at Sierra Atacama and ongoing Botswana exploration. While the share price remains strong, investors are watching whether the company can sustain operational momentum and long-term growth.

Solstice Minerals has gained momentum after strong drilling results at its Nanadie copper-gold project. The explorer is expanding its resource potential, backed by fresh funding, multiple exploration targets, and a bullish share price breakout supported by rising trading volume.